BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

495 related articles for article (PubMed ID: 27045512)

  • 81. Outcome in Hodgkin's lymphoma can be predicted from the presence of accompanying cytotoxic and regulatory T cells.
    Alvaro T; Lejeune M; Salvadó MT; Bosch R; García JF; Jaén J; Banham AH; Roncador G; Montalbán C; Piris MA
    Clin Cancer Res; 2005 Feb; 11(4):1467-73. PubMed ID: 15746048
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Genomic Analyses Identify Recurrent Alterations in Immune Evasion Genes in Diffuse Large B-Cell Lymphoma, Leg Type.
    Zhou XA; Louissaint A; Wenzel A; Yang J; Martinez-Escala ME; Moy AP; Morgan EA; Paxton CN; Hong B; Andersen EF; Guitart J; Behdad A; Cerroni L; Weinstock DM; Choi J
    J Invest Dermatol; 2018 Nov; 138(11):2365-2376. PubMed ID: 29857068
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Amphotericin B suppresses M2 phenotypes and B7-H1 expression in macrophages to prevent Raji cell proliferation.
    Zhang J; Cao D; Yu S; Chen L; Wei D; Shen C; Zhuang L; Wang Q; Xu X; Tong Y
    BMC Cancer; 2018 Apr; 18(1):467. PubMed ID: 29695237
    [TBL] [Abstract][Full Text] [Related]  

  • 84. CD68-positive tumor-associated macrophages predict unfavorable treatment outcomes in classical Hodgkin lymphoma in correlation with interim fluorodeoxyglucose-positron emission tomography assessment.
    Touati M; Delage-Corre M; Monteil J; Abraham J; Moreau S; Remenieras L; Gourin MP; Dmytruk N; Olivrie A; Turlure P; Girault S; Labrousse F; Preux PM; Jaccard A; Bordessoule D
    Leuk Lymphoma; 2015 Feb; 56(2):332-41. PubMed ID: 24766492
    [TBL] [Abstract][Full Text] [Related]  

  • 85. PD1 distribution pattern, regardless of the cell origin, is an independent microenvironmental prognostic factor for progression-free survival in follicular lymphoma.
    Szumera-Ciećkiewicz A; Poleszczuk J; Kuczkiewicz-Siemion O; Paszkiewicz-Kozik E; Rymkiewicz G; Sokół K; Borysiuk A; Kotarska M; Kawecka M; Owczarek D; Pytlak B; Walewski J; Prochorec-Sobieszek M
    Pathol Res Pract; 2020 Oct; 216(10):153096. PubMed ID: 32853965
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Triple-hit B-cell Lymphoma With MYC, BCL2, and BCL6 Translocations/Rearrangements: Clinicopathologic Features of 11 Cases.
    Wang W; Hu S; Lu X; Young KH; Medeiros LJ
    Am J Surg Pathol; 2015 Aug; 39(8):1132-9. PubMed ID: 25828391
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Cytotoxic protein expression in non-Hodgkin's lymphomas and Hodgkin's disease.
    Kanavaros P; Vlychou M; Stefanaki K; Rontogianni D; Gaulard P; Pantelidaki E; Zois M; Darivianaki K; Georgoulias V; Boulland ML; Gorgoulis V; Kittas C
    Anticancer Res; 1999; 19(2A):1209-16. PubMed ID: 10368677
    [TBL] [Abstract][Full Text] [Related]  

  • 88. High CD206 levels in Hodgkin lymphoma-educated macrophages are linked to matrix-remodeling and lymphoma dissemination.
    Arlt A; von Bonin F; Rehberg T; Perez-Rubio P; Engelmann JC; Limm K; Reinke S; Dullin C; Sun X; Specht R; Maulhardt M; Linke F; Bunt G; Klapper W; Vockerodt M; Wilting J; Pukrop T; Dettmer K; Gronwald W; Oefner PJ; Spang R; Kube D
    Mol Oncol; 2020 Mar; 14(3):571-589. PubMed ID: 31825135
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Differentiating germinal center-derived lymphomas through their cellular microenvironment.
    Carbone A; Gloghini A; Cabras A; Elia G
    Am J Hematol; 2009 Jul; 84(7):435-8. PubMed ID: 19484731
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Composite marginal zone B-cell lymphoma and classical Hodgkin's lymphoma: a clinicopathological study of 12 cases.
    Zettl A; Rüdiger T; Marx A; Müller-Hermelink HK; Ott G
    Histopathology; 2005 Feb; 46(2):217-28. PubMed ID: 15693895
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Programmed Death Ligand 1 (PD-L1) Expression in Lymphomas: State of the Art.
    Zanelli M; Fragliasso V; Parente P; Bisagni A; Sanguedolce F; Zizzo M; Broggi G; Ricci S; Palicelli A; Foroni M; Gozzi F; Gentile P; Morini A; Koufopoulos N; Caltabiano R; Cimino L; Fabozzi M; Cavazza A; Neri A; Ascani S
    Int J Mol Sci; 2024 Jun; 25(12):. PubMed ID: 38928153
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Expression of cytochrome b558 on B cell- and CD 30 positive-lymphomas.
    Shiota M; Mori S; Imajoh-Ohmi S; Nakamura M; Kanegasaki S; Serizawa H; Izumo T; Uehara T
    Pathol Res Pract; 1993 Nov; 189(9):985-91. PubMed ID: 8302731
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Clinicopathological analysis of programmed cell death 1 and programmed cell death ligand 1 expression in the tumour microenvironments of diffuse large B cell lymphomas.
    Kwon D; Kim S; Kim PJ; Go H; Nam SJ; Paik JH; Kim YA; Kim TM; Heo DS; Kim CW; Jeon YK
    Histopathology; 2016 Jun; 68(7):1079-89. PubMed ID: 26426431
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Clinico-pathological significance of immunohistochemically marked tumor-associated macrophage in classic Hodgkin lymphoma.
    Abd Allah MYY; Fahmi MW; El-Ashwah S
    J Egypt Natl Canc Inst; 2020 Apr; 32(1):18. PubMed ID: 32372254
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Refined prognostic role of CD68-positive tumor macrophages in the context of the cellular micromilieu of classical Hodgkin lymphoma.
    Tzankov A; Matter MS; Dirnhofer S
    Pathobiology; 2010; 77(6):301-8. PubMed ID: 21266828
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Immune subtyping of extranodal NK/T-cell lymphoma: a new biomarker and an immune shift during disease progression.
    Cho J; Kim SJ; Park WY; Kim J; Woo J; Kim G; Yoon SE; Ko YH; Kim WS
    Mod Pathol; 2020 Apr; 33(4):603-615. PubMed ID: 31653980
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Immune-checkpoint status in penile squamous cell carcinoma: a North American cohort.
    Cocks M; Taheri D; Ball MW; Bezerra SM; Del Carmen Rodriguez M; Ricardo BFP; Bivalacqua TJ; Sharma RB; Meeker A; Chaux A; Burnett AL; Netto GJ
    Hum Pathol; 2017 Jan; 59():55-61. PubMed ID: 27663086
    [TBL] [Abstract][Full Text] [Related]  

  • 98. A malignant lymphoma with histological features and immunophenotypic profile intermediate between EBV-positive diffuse large B-cell lymphoma and EBV-positive classical Hodgkin lymphoma in a 67-year-old female: a "gray zone" lymphoma associated with Epstein-Barr virus in the elderly.
    Wang E; Papavassiliou P; Sebastian S
    Pathol Res Pract; 2012 Jun; 208(6):363-7. PubMed ID: 22572037
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Tumor-associated macrophages in pediatric classical Hodgkin lymphoma: association with Epstein-Barr virus, lymphocyte subsets, and prognostic impact.
    Barros MH; Hassan R; Niedobitek G
    Clin Cancer Res; 2012 Jul; 18(14):3762-71. PubMed ID: 22645050
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Syncytial variant of classic Hodgkin lymphoma: Four cases diagnosed with the aid of CD274/programmed cell death ligand 1 immunohistochemistry.
    Kohno K; Sakakibara A; Iwakoshi A; Hasegawa M; Adachi S; Ishikawa E; Suzuki Y; Shimada S; Nakaguro M; Shimoyama Y; Takahara T; Takahashi E; Ohashi A; Satou A; Kato S; Asano N; Nakamura S
    Pathol Int; 2020 Feb; 70(2):108-115. PubMed ID: 31894892
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.